James To, ACA BSc(Eng) ACGI MIET, is Secretary to the Trustees of The Capricorn Foundation and The Ramsbury Manor Foundation and a consultant to the Thrombosis Research Institute having been its Institute Secretary for over 20 years. He returned to the board of Cyte in March 2025. He completed an electrical engineering degree at … Continued
Dr Georg van Husen is a senior pharmaceutical executive and independent consultant with over 20 years of global leadership in cardiovascular drug development, commercial strategy, and business transformation. Trained as a physician at RWTH Aachen University, he began his career at McKinsey & Company before joining Boehringer Ingelheim, where he advanced to Corporate Senior Vice … Continued
Lord Ajay Kakkar is President of the Thrombosis Research Institute and Emeritus Professor of Surgery, University College London. He is Chairman of King’s Health Partners, the Office for Strategic Coordination of Health Research, the King’s Fund and UK Biobank. He completed his medical degree at King’s College London and received his PhD from Imperial College … Continued
Charlotte Shyllon, FCIM, MCMI, DipPR (CAM), BSc (Hons), is the Chief Executive Officer of CYTE, devising its strategic direction as a member of the Board of Directors and with overall responsibility for driving and delivering the operational plan. Ms Shyllon has worked with CYTE from its inception, leading the Communications and Events function and more … Continued
Annalisa Jenkins, M.B.B.S., F.R.C.P. serves as a member of the Perspectum Ltd. board of directors. Dr Jenkins also serves as Chairman of the court of the London School of Hygiene and Tropical Medicine. Dr Jenkins previously served as the Chief Executive Officer of PlaqueTec Ltd. and was previously the Chief Executive Officer and a member … Continued
